<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="4608">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03046940</url>
  </required_header>
  <id_info>
    <org_study_id>2016-37v-r</org_study_id>
    <nct_id>NCT03046940</nct_id>
  </id_info>
  <brief_title>The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication</brief_title>
  <official_title>The Influence of Doctor-patient Communication on Patients' Willingness to Take Medication</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Philipps University Marburg Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Philipps University Marburg Medical Center</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The experiment aims at investigating whether the doctor-patient communication has an
      influence on patients' willingness to take medication. Patients' attitude towards the
      medication is manipulated via a critical film sequence. Afterwards patients of the two
      experimental groups have a communication with one of the investigators of the study.
      Patients are told that the investigator is a medical doctor. The &quot;doctors&quot; either
      communicate in a patient-centered or doctor-centered style with the patient. Patients in the
      control group do not have the possibility to talk to a &quot;medical doctor&quot;. Afterwards patients
      are offered the aforementioned pill that is supposed to be a cognitive enhancer (actually
      placebo pill). Pill intake is voluntary. The investigators hypothesize that patients in the
      experimental group with the patient-centered style of communication are more likely to take
      the pill than patients in the experimental group with the doctor-centered style of
      communication or patients in the control group.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 15, 2017</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Investigator</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pill intake</measure>
    <time_frame>Within 10 minutes after doctor-patient communication</time_frame>
    <description>Behavioural test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Willingness to take medication (VAS)</measure>
    <time_frame>Within 10 minutes prior to watching the film sequence, directly (within 5 minutes) after the film sequence, directly (within 10 minutes) after doctor-patient communication</time_frame>
    <description>Visual analogue scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Critical attitude towards the medication (VAS)</measure>
    <time_frame>Within 10 minutes prior to watching the film sequence, directly (within 5 minutes) after the film sequence, directly (within 10 minutes) after doctor-patient communication</time_frame>
    <description>Visual analogue scale (VAS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence on concentration (Concentration task)</measure>
    <time_frame>Directly (within 10 minutes) after the pill was offered</time_frame>
    <description>Concentration task</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No communication with a doctor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient-centered</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants communicate with a doctor that uses a patient-centered style of communication</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Doctor-centered</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants communicate with a doctor that uses a doctor-centered style of communication</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Patient-centered style of communication</intervention_name>
    <description>Different doctor-patient communication</description>
    <arm_group_label>Patient-centered</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Doctor-centered style of communication</intervention_name>
    <description>Different doctor-patient communication</description>
    <arm_group_label>Doctor-centered</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  female

          -  between 18 and 35 years

          -  healthy

          -  adequate ability to see

          -  fluent in German (reading and writing)

        Exclusion Criteria:

          -  regular intake of cognitive enhancers/medication that enhances concentration

          -  intake of psychotropic drugs

          -  medical or pharmacy students, advanced psychology students

          -  participants who know the investigators
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Winfried Rief, PhD, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Philipps University Marburg Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julia Rheker, PhD</last_name>
    <email>julia.rheker@staff.uni-marburg.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Frauke Wei√ü</last_name>
    <email>frauke.weiss@staff.uni-marburg.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Department of Clinical Psychology and Psychotherapy, Philipps-University Marburg</name>
      <address>
        <city>Marburg</city>
        <zip>35032</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julia Wittkowski</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>April 4, 2017</lastchanged_date>
  <firstreceived_date>January 30, 2017</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Philipps University Marburg Medical Center</investigator_affiliation>
    <investigator_full_name>Winfried Rief</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
